Achievements and Limitations of Evidence-Based Medicine

被引:59
作者
Sheridan, Desmond J. [1 ]
Julian, Desmond G. [2 ]
机构
[1] Univ London Imperial Coll Sci Technol & Med, Div Natl Heart & Lung Inst, Guy Scadding Bldg,Royal Brompton Campus, London SW3 6NP, England
[2] Netherhall Gardens, London, England
关键词
advocacy; campaign; clinical decision-making; public health; United Kingdom; United States; RESEARCH-AND-DEVELOPMENT; MYOCARDIAL-INFARCTION; CARDIAC-REHABILITATION; RANDOMIZED-TRIALS; DRUGS; DISEASE; LONG;
D O I
10.1016/j.jacc.2016.03.600
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Evidence-based medicine (EBM) has a long history, but was revived in the early 1990s by a campaign mounted by a movement that took its name. The EBM movement focused attention on the need for greater objectivity in medical decision-making and led to the Cochrane Collaboration, which provides reviews of evidence on the basis of comparative research. Important limitations of EBM's effect on medicine have also emerged. Failure to acknowledge the limitations of clinical trials and systematic reviews has limited their applicability to individual patients' circumstances. An almost exclusive focus on drugs and devices has left vast areas of health care in an evidence vacuum. An overdependence on commissions for its research may have limited its independence in selecting what it investigates. EBM needs to widen its scope beyond drugs and devices to address many areas that often lack evidence at present, notably, health policy, management, and reforms. (C) 2016 by the American College of Cardiology Foundation.
引用
收藏
页码:204 / 213
页数:10
相关论文
共 66 条
[1]   Mechanisms: what are they evidence for in evidence-based medicine? [J].
Andersen, Holly .
JOURNAL OF EVALUATION IN CLINICAL PRACTICE, 2012, 18 (05) :992-999
[2]  
[Anonymous], 1990, BMJ, V301, P651
[3]  
[Anonymous], 2001, REP PUBL INQ CHILDR
[4]  
[Anonymous], 2014, PARLIAMENT MAGAZINE
[5]  
[Anonymous], ANN REP FIN STAT 201
[6]  
[Anonymous], 1918, REP MACH GOV COMM
[7]  
[Anonymous], Public Health, DOI DOI 10.1016/S0033-3506(02)00027-6
[8]  
[Anonymous], 1971, FRAMEWORK GOVT RES D
[9]   Approach to symptomatic coronary disease in the elderly: TIME to change? [J].
Aronow, WS .
LANCET, 2001, 358 (9286) :945-946
[10]  
Belmont Report [1979]-National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research, 2013, BELM REP ETH PRINC G